Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M783Revenue $M10.8Net Margin (%)-6,286.4Altman Z-Score8.1
Enterprise Value $M614EPS $-1.2Operating Margin %-6,270.1Piotroski F-Score2
P/E(ttm)--Beneish M-Score23.1Pre-tax Margin (%)-6,250.3Higher ROA y-yN
Price/Book4.610-y EBITDA Growth Rate %--Quick Ratio4.8Cash flow > EarningsY
Price/Sales3785-y EBITDA Growth Rate %--Current Ratio5.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-85.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-103.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M104ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with KERX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
KERXSeth Klarman 2015-03-31 Add0.88%$10.87 - $14.68
($12.86)
$ 8.21-36%Add 22.30%22,380,200
KERXSeth Klarman 2014-09-30 Add1.87%$12.71 - $18.19
($15.32)
$ 8.21-46%Add 73.62%18,300,000
KERXSeth Klarman 2014-06-30 Add1.04%$12.11 - $17.03
($14.16)
$ 8.21-42%Add 67.01%10,539,986
KERXSeth Klarman 2014-03-31 Buy 2.6%$12.16 - $16.88
($14.98)
$ 8.21-45%New holding6,310,850
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

KERX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


KERX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Adams BrianVP and General Counsel 2015-07-15Sell1,086$9.99-17.82view
Oliviero James F IIICFO 2015-07-06Sell1,943$9.61-14.57view
Tarnok Michael P.Director 2015-05-06Buy10,000$9.73-15.62view
Adams BrianVP and General Counsel 2015-04-15Sell4,320$12.4-33.79view
Oliviero James F IIICFO 2015-04-06Sell1,878$11.68-29.71view
BENTSUR RONCEO 2015-04-06Sell1,592$11.68-29.71view
Madison GregPresident and COO 2015-03-06Buy6,380$12.53-34.48view
Madison GregPresident and COO 2015-02-09Sell6,759$10.95-25.02view
BENTSUR RONCEO 2015-01-05Sell5,574$13.79-40.46view
Oliviero James F IIICFO 2015-01-05Sell5,604$13.79-40.46view

Quarterly/Annual Reports about KERX:

News about KERX:

Articles On GuruFocus.com
main Jul 01 2015 
main Jul 01 2015 
Is Seth Klarman right about Keryx Inc.? Jun 25 2015 
Seth Klarman Buys Pioneer Natural Resources, SunEdison Semiconductor Ltd, Atara Biotherapeutics Inc, May 15 2015 
my portfolio May 08 2015 
Analysts Positive on Keryx Biopharmaceuticals, Inc. Despite Weak Prescription Data May 05 2015 
Roth Capital Weighs In On 5 Biotech Stocks to Watch Apr 05 2015 
Portfolio Feb 16 2015 
2015 Must-Buys In Biotech Sector Feb 02 2015 
me Jan 23 2015 

More From Other Websites
Keryx Biopharmaceuticals to Host Conference Call of Second Quarter 2015 Financial Results on... Jul 28 2015
Keryx Biopharmaceuticals to Host Conference Call of Second Quarter 2015 Financial Results on... Jul 28 2015
KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers,... Jul 27 2015
Keryx Biopharmaceuticals Appoints Scott A. Holmes as Chief Financial Officer Jul 27 2015
8:02 am Keryx Biopharma appoints Scott Holmes as CFO; will succeed James Oliviero whose planned... Jul 27 2015
Keryx Biopharmaceuticals Appoints Scott A. Holmes as Chief Financial Officer Jul 27 2015
Keryx Receives CHMP Positive Opinion for Fexeric(R) (Ferric Citrate Coordination Complex) for the... Jul 24 2015
Keryx Receives CHMP Positive Opinion for Fexeric(R) (Ferric Citrate Coordination Complex) for the... Jul 24 2015
Faruqi & Faruqi, LLP is Investigating Keryx Biopharmaceuticals, Inc. (KERX) on Behalf of its... Jul 16 2015
Blame Keryx Executives, Not Short Sellers, for Dismal Drug Launch, Sinking Stock Jul 07 2015
Edited Transcript of KERX presentation 24-Jun-15 6:30pm GMT Jun 29 2015
KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 24 2015
​Boston drug company Keryx continues to shake off the haters Jun 24 2015
Keryx Announces Two National Insurance Providers Added Auryxia(TM) to Their Medicare Part D... Jun 24 2015
Keryx Announces Two National Insurance Providers Added Auryxia(TM) to Their Medicare Part D... Jun 24 2015
KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 17 2015
Keryx Biopharmaceuticals to Present at the JMP Securities Life Sciences Conference 2015 Jun 16 2015
Keryx Biopharmaceuticals to Present at the JMP Securities Life Sciences Conference 2015 Jun 16 2015
MKM Partners' 4 Health Care Stocks to Sell Before June May 27 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK